With little access to doctors, drug firms go digital to stay relevant

The rise of e-pharmacies and tele-consultations during Covid-19 has made it easier for healthcare companies to access patient pools

Soon a physician may be browsing through a online platform that would curate information for him on therapies, treatements, and diseases in an innovative manner - through videos, write-ups and such like. With free movement being curbed, access to doctors becoming restricted and fresh prescription generation taking a hit, drug firms are looking at ramping up their digital strategies when it comes to marketing and promotions. 

Industry observers say that with lower cases in smaller towns, clinic visits and prescription generation continue. Through the digital medium, companies that do not traditionally have field force in these areas, can attempt to